Natural Product: NPC18809

Natural Product IDNPC18809
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
BCFNGCHELGNCOO-DXTJESGOSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 21608712
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002755] Aspidospermatan-type alkaloids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BCFNGCHELGNCOO-DXTJESGOSA-N
Standard InCHI InChI=1S/C42H48N4O4/c1-3-39-19-24-18-38(23-46-29-11-7-5-9-27(29)42(32(24)46)13-15-44(35(39)42)21-30-33(39)50-30)22-45-16-12-41-26-8-4-6-10-28(26)43-31(41)25(34(47)48-2)20-40(36(41)45)14-17-49-37(38)40/h4-11,24,30,32-33,35-37,43H,3,12-23H2,1-2H3/t24-,30-,32+,33-,35+,36+,37+,38+,39-,40+,41+,42+/m1/s1
SMILES CC[C@@]12C[C@H]3C[C@]4(CN5CC[C@]67c8ccccc8NC6=C(C[C@@]6(CCO[C@@H]46)[C@H]57)C(=O)OC)CN4c5ccccc5[C@@]5(CCN(C[C@@H]6[C@H]1O6)[C@@H]25)[C@H]34

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   672.37 Volume:   681.81
?
Van der Waals volume.
Dense:   0.986 LogP:   3.635
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.176
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.313
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   57.0
TPSA:   69.81
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   1.0 Rings:   13.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.36 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.004 Fsp3:   0.643
MCE-18:   333.391
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.869 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.416
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.308
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.42

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.237 MDCK Permeability:   -4.836
Pgp-inhibitor:   0.001 Pgp-substrate:   1.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.837 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.999 MRP1:   0.994
Plasma Protein Binding (PPB):   90.407% Volume Distribution (VD):   0.782
Fu: 9.369%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.9
OATP1B3 inhibitor:   0.105 BCRP inhibitor:   0.007
BSEP inhibitor:   0.992

ADMET: Metabolism

CYP1A2-inhibitor:   1.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.997
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.197
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.047
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  12.786 Half-life (T1/2):  0.936

ADMET: Toxicity

hERG Blockers:  0.53 hERG Blockers (10um):  0.671
Human Hepatotoxicity (H-HT):  0.861 Drug-induced Liver Injury (DILI):  0.467
AMES Toxicity:  0.457 Rat Oral Acute Toxicity:  0.792
Maximum Recommended Daily Dose:  0.937 Skin Sensitization:  0.932
Carcinogencity:  0.243 Eye Corrosion:  0.0
Eye Irritation:  0.001 Respiratory Toxicity:  0.937
Drug-induced Neurotoxicity:  0.685 Ototoxicity:  0.935
Hematotoxicity:  0.654 Drug-induced Nephrotoxicity:  0.954
Genotoxicity:  0.999 RPMI-8226 Immunitoxicity:  0.068
A549 Cytotoxicity:  0.301 Hek293 Cytotoxicity:  0.572
BCF:   2.183
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.791
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.232
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.838
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40369 Tabernaemontana pachysiphon Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[33112136]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 > 10000.0 nM PMID[33112136]
NPT81 Cell line A549 Homo sapiens IC50 > 10000.0 nM PMID[33112136]
NPT396 Cell line T47D Homo sapiens IC50 > 10000.0 nM PMID[33112136]
NPT170 Cell line SK-MEL-28 Homo sapiens IC50 > 10000.0 nM PMID[33112136]
NPT660 Cell line SW480 Homo sapiens IC50 > 10000.0 nM PMID[33112136]
NPT65 Cell line HepG2 Homo sapiens IC50 > 10000.0 nM PMID[33112136]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC18809 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC199826
0.7913 Intermediate Similarity NPC485978
0.7913 Intermediate Similarity NPC485973
0.7647 Intermediate Similarity NPC208310
0.7647 Intermediate Similarity NPC301174
0.7373 Intermediate Similarity NPC485975
0.7167 Intermediate Similarity NPC223242
0.7073 Intermediate Similarity NPC485971
0.6935 Remote Similarity NPC139373
0.6457 Remote Similarity NPC485974
0.6457 Remote Similarity NPC485979
0.6408 Remote Similarity NPC159963
0.5789 Remote Similarity NPC208572
0.5778 Remote Similarity NPC301501
0.562 Remote Similarity NPC62560
0.558 Remote Similarity NPC485976
0.554 Remote Similarity NPC485972
0.5468 Remote Similarity NPC469450
0.539 Remote Similarity NPC469451
0.5385 Remote Similarity NPC485977
0.5133 Remote Similarity NPC195636
0.5043 Remote Similarity NPC19175

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC18809 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data